Category: New products
-
Trial to Test CBD for Parkinson’s-Related Psychosis
A clinical trial is planned to test cannabidiol, or CBD, derived from cannabis as a treatment for hallucinations and delusions among people with Parkinson’s disease.
-
Nanoparticles Designed to Cross Blood-Brain Barrier
Nanoscale particles derived from viruses are shown in tests with lab mice to cross the blood-brain barrier, and reach nerve cells in the brain.
-
NSF Funds Blockchain Health Care Data System
A new grant finances design of a lower-cost health care data network built with blockchain that promises to preserve patients’ security and privacy.
-
A.I. Image Analysis Computes Stroke Damage
A review study shows an analysis of CT scans using artificial intelligence matches calculations of damage from stroke made with more advanced imaging.
-
Peanut Allergy Patch Under FDA Review
A device to build a tolerance of peanuts in children with a peanut allergy, worn like a patch on the skin, is under review by the Food and Drug Administration.
-
Dementia Drug Candidate in Preclinical Tests
A study is underway of a new treatment approach for dementia that targets inflammation and microscopic bleeding in the brain that can accompany Alzheimer’s disease.
-
App Detects Early Eye Disease Symptoms from Photos
In tests with thousands of children’s photographs, a smartphone app shows it can detect early symptoms of serious eye diseases, including cancer.
-
Small Biz Grant Funds Prenatal Genetic Test
A small business set-aside grant is funding early development of a non-invasive prenatal test that simplifies detection of genetic abnormalities in a fetus.
-
Leg Prosthetic System Restores Sensory Feedback
Results from a small clinical trial shows a system for leg prosthetic devices restores tactile sensory feedback to improve mobility and reduce falling.
-
Nanotech Crispr Delivery in Development
Researchers in biochemistry and structural biology are designing a technique using nanoscale particles to safely deliver edited genes as a cancer treatment.